Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $2.20
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $100.0K | $250.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $20.7K | $29.0K | $14.0K | $15.0K | $11.8K | $5.7K |
| Gross profit | $100.0K | $250.0K | −$20.7K | −$29.0K | −$14.0K | −$15.0K | −$11.8K | −$5.7K |
| Gross margin | 100.0% | 100.0% | — | — | — | — | — | — |
| R&D | $15.8M | $388.8K | $403.0K | $799.6K | $0 | $0 | $279.5K | $772.7K |
| Operating income | −$28.4M | −$8.2M | −$7.9M | −$6.8M | −$12.1M | −$4.6M | −$3.8M | −$3.6M |
| EBITDA | −$26.5M | −$7.3M | −$7.5M | −$6.8M | −$13.2M | −$4.2M | −$3.8M | −$1.6M |
| Net income | −$35.0M | −$12.7M | −$7.2M | −$6.7M | −$13.2M | −$4.2M | $400.4K | −$1.59B |
| Net margin | -34986.0% | -5085.6% | — | — | — | — | — | — |
| EPS (diluted) | -146.00 | -41.00 | -22.00 | -19.34 | -35.52 | -11.00 | 0.68 | -3210.89 |
Annual figures · source: Financial Modeling Prep
LADRX CORPORATION
No one on the platform currently holds LADX.
No tracked institution reports a position in LADX as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-05-17 | 1-for-100reverse |
No one on the platform has traded LADX yet.
| $53193 |
| — |
| MEDVFMedivolve Inc. | $0.00 | +0.00% | $2702 | — |
| MHTXManhattan Scientifics, Inc. | $0.00 | +0.00% | $11186 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.